NOVA IMMUNOTHERAPEUTICS LIMITED
NOVA IMMUNOTHERAPEUTICS LIMITED is a private limited company registered in the United Kingdom, under 09062628, incorporated on 29 May 2014. The company is currently active. Operates in the research and experimental development on biotechnology sector (SIC 72110). The company has been operating for 12 years. Registered office address: LE18 4YL Wigston, the United Kingdom. Formerly known as NOVA MERCIA LIMITED. Directors include MRS KAREN ALISON LEISHMAN, MR JAMES ANDREW PITT WHITE, and DR PETER JOHN PITT WHITE. Sole shareholder is NOVA BIO-PHARMA HOLDINGS LIMITED. Associated with 11 related entities, including NOVA ADVANCED TISSUE ENGINEERING LIMITED, 06951295, and NOVA BIO-PHARMA HOLDINGS LIMITED. No sanctions, PEP status, or adverse risk signals are currently on record. Data sourced from UK Companies House.
Official Identifiers
Name Registry
NOVA MERCIA LIMITED
Registered Address
MARTIN HOUSE
GLOUCESTER CRESCENT
LEICESTERSHIRE
LE18 4YL WIGSTON
the United Kingdom
Signal Intelligence
No sanctions, PEP status, or adverse risk signals are currently on record for this entity.
Key Management & Controllers
Associated Entities
Companies sharing one or more directors or officers with this entity.
Source Records (1)
| companieshouse | 09062628 | 2026-06-01 | open_in_new |